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HBV replicationIdentifying the requirements for the regulatory HBx protein in hepatitis B virus (HBV) replication is an
important goal. A plasmid-based HBV replication assay was used to evaluate whether HBx subcellular
localization inﬂuences its ability to promote virus replication, as measured by real time PCR quantitation of
viral capsid-associated DNA. HBx targeted to the nucleus by a nuclear localization signal (NLS-HBx) was able
to restore HBx-deﬁcient HBV replication, while HBx containing a nuclear export signal (NES-HBx) was not.
Both NLS-HBx and NES-HBx were expressed at similar levels (by immunoprecipitation and Western
blotting), and proper localization of the signal sequence-tagged proteins was conﬁrmed by deconvolution
microscopy using HBx, NLS-HBx, and NES-HBx proteins fused to GFP. Importantly, these ﬁndings were
conﬁrmed in vivo by hydrodynamic injection into mice. Our results demonstrate that in these HBV
replication assays, at least one function of HBx requires its localization to the nucleus.© 2009 Elsevier Inc. All rights reserved.IntroductionChronic infection with hepatitis B virus (HBV) is a signiﬁcant
risk factor for the development of hepatocellular carcinoma
(Beasley et al., 1981). Despite the recognized public health concern
of HBV, little progress has been made in deﬁning the critical virus–
cell interactions that underlay the initiation of virus infection and
maintenance of the chronic state. Such knowledge is necessary for
designing rational therapies that will interrupt chronic HBV
replication.
HBV encodes a 17-kDa regulatory HBx protein whose role in virus
replication remains undeﬁned. Studies of HBx in transfected cells
have identiﬁed a number of functions that are thought to be
important for HBV replication and pathogenesis, including effects
on cell cycle, cytoplasmic signaling, DNA repair, and apoptosis
[reviewed in Bouchard and Schneider (2004)]. However, the link
between these properties of HBx in cell culture, and virus replication
remains unproven.
It is established that HBx can localize to either the cytoplasm or
the nucleus of infected liver cells (Dandri et al., 1998; Doria et al.,
1995; Haruna et al., 1991; Henkler et al., 2001; Hoare et al., 2001;
Nomura et al., 1999; Su et al., 1998; Wang et al., 1991), and it is
reasonable to anticipate that HBx may exert different effects on virusHouston, TX 77030, USA. Fax:
478, USA.
Microbiology, George Mason
ll rights reserved.replication and/or pathogenesis in different subcellular compart-
ments. Furthermore, studies reveal that a subset of cytoplasmic HBx
may be associated with the mitochondria (Clippinger and Bouchard,
2009; McClain, 2007; Rahmani et al., 2000; Takada et al., 1999; Waris
et al., 2001). The function of HBx in these subcellular compartments
is an important issue.
The recent descriptions of models that recapitulate portions of
the HBV replication cycle (Bouchard et al., 2002; Yang et al., 2002)
provide an opportunity to directly examine functions of HBx within
the context of virus replication. In HepG2 cells, virus replication
from an HBx-deﬁcient HBV plasmid (Bouchard et al., 2002; Melegari
et al., 1998) is signiﬁcantly reduced compared to replication from an
HBx-proﬁcient HBV plasmid (Bouchard et al., 2002; Keasler et al.,
2007; Leupin et al., 2005; Melegari et al., 1998; Tang et al., 2005).
The requirement for HBx in virus replication has also been
established in hydrodynamically-injected mice, where HBx-deﬁcient
replication is reduced to just 1% of HBx-proﬁcient replication
(Keasler et al., 2007). HBx provided in trans on a second plasmid
restores HBx-deﬁcient replication to wildtype (HBx-proﬁcient)
levels in both HepG2 cells and mouse hepatocytes in vivo.
Interestingly, there is no difference between HBx-proﬁcient replica-
tion and HBx-deﬁcient replication in human liver HuH7 cells,
although the mechanism for that observation is not known
(Melegari et al., 1998).
Previous studies to address a role of HBx subcellular localization
in virus replication have not yielded deﬁnitive conclusions. One study
reported that NLS-HBx was unable to restore HBx-deﬁcient wood-
chuck hepatitis virus (WHV) replication, but did not include NES-
HBx as a positive control for cytoplasmic HBx (Klein et al., 2001). In
addition, that study utilized Chang cells (http://www.atcc.org.
Fig. 1. Schematic representation of the X gene constructs used. Expression of the 154-aa
HBx (subtype adw2; designated as black bar) was from the pSI vector containing the
SV40 early region enhancer/promoter (Brondyk,1994). Variants of HBxwere created by
cloning one or more of the following in frame with HBx: NLS, nuclear localization
signal; NES, nuclear export signal; GFP, green ﬂuorescence protein. pSI-X plasmids
without GFP were used in functional replication assays, while GFP fusion proteins were
used to validate the NLS and NES localization signals.
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replication. A second study was performed with HepG2 cells, but
used plasmid vectors (for HBx, NLS-HBx, and NES-HBx) that were
expressed fused to green ﬂuorescence protein (GFP) (Leupin et al.,
2005). The effect of the longer-lived GFP protein [half-life, 26 h;
(Corish and Tyler-Smith, 1999)] on HBx [reported half-life ∼30 min
(Schek et al., 1991; Sirma et al., 1998) and 3 h (Schek et al., 1991)]
was not examined, and so it is possible that HBx may have been
expressed to high levels. Therefore, the goals of the present study
were to characterize the HBV replication assay to establish its sensi-
tivity for HBx function, and to examine the ability of HBx targeted to
the nucleus or the cytoplasm to complement HBx-deﬁcient pHBVΔX




Recent HBV replication models utilize plasmid DNA encoding a
greater-than-unit length (120%) wildtype HBV (pHBV) (Scaglioni
et al., 1997) which express HBV proteins, including HBx (McClain
et al., 2007) under control of the native HBV enhancers and
promoters. Previous studies addressed the ability of nuclear- and/
or cytoplasmic localized HBx to restore HBx-deﬁcient (pHBVΔX)
replication (Klein et al., 2001; Leupin et al., 2005) utilizing the
cytomegalovirus (CMV) early promoter (Brondyk, 1994) and the SRα
promoter (Takebe et al., 1988) that are each anticipated to drive HBx
expression to high levels (Table 1). High levels of HBx are reported to
aggregate within the cytoplasm and to affect cell cycling (Henkler
et al., 2001; Hoare et al., 2001; Song et al., 2003), which may
inﬂuence the interpretation of those results. Therefore, we began our
study by re-creating a panel of plasmid DNAs in which expression of
HBx (and its signal-tagged derivatives) was driven from the SV40
early promoter/enhancer (Brondyk, 1994) (Fig. 1). All HBx sequences
are from the adw2 subtype of HBV, and based on relative promoter
strengths (Table 1) are predicted to express HBx at lower levels than
in previous studies (Klein et al., 2001; Leupin et al., 2005).
Dose-dependent rescue of HBx-dependent replication in HepG2 cells
A titration experiment was used to deﬁne levels of HBx required
for maximal levels of virus replication. HepG2 cells were transfected
with either pHBV or pHBVΔX, and plates of cells receiving pHBVΔX
were co-transfected with pSI-X diluted over a 1000-fold range. Cells
were harvested at 5-days and capsid-associated viral DNA quantitated
by real time PCR. Viral copy number in cells transfected with pHBVTable 1
Effect of HBx subcellular localization on levels of HBV capsid-associated DNA.
Cell type HBxa Promoterb Promo
Chang livere NLS-HBx pCMV 1.8 to 6
HepG2f NLS-GFP-HBx pSRα 40
NES-GFP-HBx pSRα 40
HepG2 NLS-HBx pSI 1
NES-HBx pSI 1
Mouse (viremia)g NLS-HBx pSI 1
NES-HBx pSI 1
a HBx expressed from transfected plasmid DNA as an in-frame fusion protein with one or
green ﬂuorescence protein.
b Promoter used to drive HBx expression: CMV, human cytomegalovirus immediate-early
leukemia virus I long terminal repeat fused to the SV40 early promoter-enhancer (Takebe e
c Strength of given promoter relative to the SV40 early promoter/enhancer, as described
d Ability of a speciﬁc version of HBx to restore HBx-deﬁcient pHBVΔX replication in tran
e Chang liver cells, reported to be cervical cancer cells (http://www.atcc.org, search term
f HepG2, hepatocyte cell line derived from human hepatoblastoma (Aden et al., 1979).
g HBV replication in mice hydrodynamically injected as described in Materials and methwas set to 100%, and replication from pHBVΔX (alone or with varying
amounts of complementing pSI-X) was compared to that level.
Replication from pHBVΔX was reduced to 40% of that detected in
cells transfected with pHBV (Fig. 2A), a result that conﬁrms our pre-
vious ﬁndings (Keasler et al., 2007). We show that pSI-X was able to
restore HBVΔX replication to wildtype (pHBV) levels when added at
1-, 0.1-, or 0.01-μg per 60-mm plate, but that 0.001-μg pSI-X restored
pHBVΔX replication to levels still signiﬁcantly reduced from the pHBV
wildtype levels (Fig. 2A; see asterisk). Importantly, to consistently
detect HBx by IP/Western, it is necessary to pool two 60-mm plates of
HepG2 cells each transfected with 1 μg pSI-X DNA (Fig. 3B). These
results show that HBx can fully restore pHBVΔX replication when
expressed at levels below the limit of detection by our sensitive IP/
Western blot assay.
We next established that the viral DNA detected by real time PCR
was from encapsidated DNA and not from residual input plasmid
DNA. HepG2 cells were transfected with pHBV, lysed at day 5, and
viral capsids puriﬁed and treated with DNaseI to digest non-
encapsidated DNA that might stick to the outside of the cores. Viral
capsids were then either disrupted by addition of SDS and proteinase
K (Fig. 2B, black bar), or left untreated and presumably intact (Fig. 2B,
white bar) prior to real time PCR quantitation of capsid-associated
viral DNA. Virus copy number per cell from SDS/proteinase K-
disrupted capsids was set to 100%, and compared to that measured
from capsids not disrupted by SDS/proteinase K. There was a 95%ter strengthc Rescue of ΔX replication?d Reference
.5 No Klein et al., 2001
Yes Leupin et al., 2005





more of the following: NLS, nuclear localization signal; NES, nuclear export signal; GFP,
enhancer/promoter region (Brondyk, 1994); pSRα, R-U5 segment from the human T cell
t al., 1988); pSI, SV40 early region promoter/enhancer (Brondyk, 1994).
(Brondyk, 1994; Takebe et al., 1988).
s, compared to wildtype HBV pHBV levels of replication.
: CCL-13).
ods.
Fig. 2. HBx and HBV replication. Panel A, HepG2 cells were transfected with pHBV, pHBVΔX, pHBVΔX plus pSI-X (1 to 0.001 μg), or a negative control plasmid (Ctrl) and virus
replication measured by real time PCR. Viral DNAwas normalized to the number of transfected cells (determined by cotransfection of plasmid DNA encoding GFP) and is reported as
the average of 3 experiments±SEM. The statistical signiﬁcance of reduced HBV expression was determined by comparison to HBV replication measured from the pHBV (wildtype)
plasmid, and is noted by an asterisk above the bar (pb0.05). Panel B, Copies of viral DNAmeasured by real time PCR from core particles disruptedwith SDS/Proteinase K (black bar) or
left untreated (white bar). Copies of capsid-associated viral DNA detected from cells transfected with pHBV and treated with SDS/proK (black bar) was set to 100% and the relative
levels of viral DNA detected in cells transfected with pHBV and no SDS/proK (white bar) or a control plasmid (Ctrl.) are reported±SEM.
124 V.V. Keasler et al. / Virology 390 (2009) 122–129reduction in capsid-associated viral DNA detected from samples that
were left intact (Fig. 2B, white bar). These results indicate that viral
capsids must be disrupted in order to measure viral DNA by real time
PCR in this assay. Together, the pSI-X titration (Fig. 2A) and the
treated/untreated capsid control experiment (Fig. 2B) provide
evidence that the role of HBx in virus replication can be measured
at very low levels of HBx expression.Fig. 3. HBx and NLS-HBX rescue of HBx-deﬁcient replication. Panel A, HepG2 cells
were transfected with pHBV or pHBVΔX, with the latter co-transfected with pSI-X,
pSI-NLS-HBX, pSI-NES-HBX, or a negative control plasmid. Virus replication was
measured using real time PCR quantitation of capsid-associated DNA. Data is reported
as HBV copy number (% of HBV control) from three experiments±SEM. Statistical
signiﬁcance compared to pHBV is noted by an asterisk above the bar (pb0.05). Panel
B, HepG2 cells were transfected with pSI-X (lane 1), pSI-NLS-HBX (lane 2), pSI-NES-
HBX (lane 3), or a negative control plasmid (lane 4) and harvested 48 h post-
transfection. Detection of HBx was by IP/Western.Restoration of HBx-deﬁcient replication by nuclear-localized HBx
HBx has been detected in both the cytoplasm and the nucleus of
HBV-infected hepatocytes and cultured cells transfected with
plasmid DNAs encoding HBx. To determine which subcellular loca-
tion is critical for virus replication, pSI-HBx, pSI-NLS-HBx, and pSI-
NES-HBx expression plasmids (Fig. 1) were tested for their ability to
restore pHBVΔX replication. Cells transfected with pHBVΔX had
levels of capsid-associated DNA that were 34% of that measured in
cells transfected with pHBV (Fig. 3A). Capsid-associated viral DNA
levels were restored to maximal levels by either pSI-X or pSI-NLS-
HBx, but were not restored by pSI-NES-X (Fig. 3A). This result is
consistent with a previous report that a GFP-NLS-HBx fusion protein
could restore HBx-deﬁcient replication while a similar GFP fusion
protein tagged with an NES signal could not (Leupin et al., 2005).
Although that study did not examine GFP-HBx expression levels, our
present study revealed that HBx (and NLS-HBx) rescue pHBVΔX
replication using levels of HBx below the limits of detection of our
sensitive IP/Western blot assay.
The failure of NES-HBx to restore pHBVΔX replication was
unexpected, given the prevalent idea that HBx function in the cyto-
plasm is important to virus replication [reviewed in (Ganem and
Schneider, 2001)]. We next investigated the possibility that NES-HBx
was inherently less stable than NLS-HBx. Plasmid-transfected HepG2
cells were lysed at 48 h and analyzed for steady-state HBx levels by IP/
Western as described in Materials and methods. Both the NLS-HBx
and the NES-HBx proteins migrated at an apparent molecular weight
slightly higher than wildtype HBx due to the presence of the added
localization signals (Fig. 3B; compare lane 1 with lanes 2 and 3). We
consistently found a weaker Western blot signal for the NLS-HBx and
NES-HBx proteins, relative to that for wildtype HBx, even though all
three proteins are expressed from the same pSI plasmid vector.
Importantly, the NLS-HBx and the NES-HBx proteins are expressed at
similar levels, indicating that the inability of NES-HBx to restore HBx-
deﬁcient replication cannot be explained by reduced protein stability
relative to NLS-HBx. We note that other laboratories have found that
the addition of the NLS signal, or the Flag epitope tag, to either end of
the HBx protein did not effect the ability of HBx to transactivate HBx
responsive elements (Nomura et al., 1999) or to induce calcium
release (McClain et al., 2007), respectively.
Fig. 5. HBx and NLS-HBX complementation of HBx-deﬁcient replication in vivo. Mice
were injected with pHBV (ﬁlled circles; n=6), pHBVΔX (open circles; n=5), pHBVΔX
plus pSI-X (ﬁlled triangles; n=6), pHBVΔX plus pSI-NLS-X (open triangles; n=6),
pHBVΔX plus pSI-NES-X (ﬁlled square; n=5), or negative control plasmid (n=4).
Blood was collected via retroorbital bleeding on days 0, 2, 4, 5, 7, and 10 post-injection.
Capsid-associated viral DNA was puriﬁed from serum and quantitated by real time
PCR. The horizontal dashed line near the bottom of the graph represents the
background copies of HBV DNA from the real time PCR reaction (1 copy per μl serum).
Error bars represent±SEM and statistical signiﬁcance (compared to pHBV levels) is
designated with an asterisk.
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were localized to the correct subcellular compartment. For these
experiments, HBx, NLS-HBx and NES-HBx were cloned as in-frame
fusion proteins with GFP at the C-terminus, expressed by the same
SV40 early promoter (Fig. 1). HepG2 cells were then transfected,
ﬁxed at 24-hr post-transfection, and processed for analysis by decon-
volution ﬂuorescence microscopy. Expression of the wildtype HBx-
GFP was detected in both the nucleus and cytoplasm of transfected
cells (Figs. 4A, D, G). In cells transfected with pSI-NLS-HBx-GFP,
localization was primarily to the nucleus, although some cytoplasmic
localization was detected (Figs. 4B, E, H), consistent with the report
that HBx may possess a nuclear export signal (Forgues et al., 2001).
In cells transfected with pSI-NES-HBx-GFP, the majority of ﬂuores-
cence was localized to the cytoplasm (Figs. 4C, F, I). These data
conﬁrm that the X-GFP fusion proteins containing an NLS or NES
localization sequence are targeted to the proper subcellular location.
NLS-HBx restores HBx-deﬁcient HBV replication in vivo
We previously reported that in the hydrodynamic injection
model, HBx-deﬁcient pHBVΔX replication was reduced by 99%
relative to HBx-proﬁcient replication (Keasler et al., 2007). This
model was next used to examine the ability of NLS- and NES-HBx to
restore pHBVΔX replication in vivo. Eleven outbred ICR mice were
injected with either wildtype pHBV (n=6) or HBx-deﬁcient pHBVΔX
(n=5). Additional mice injected with pHBVΔX were co-injected
with pSI-X (n=6), pSI-NLS-X (n=6), or pSI-NES-X (n=5). Finally, 4
mice received a negative control plasmid. All 32 mice used in this
study were also co-injected with pSI-SEAP (a secretable form of
alkaline phosphatase) to normalize injection efﬁciency among
groups. Blood was collected by retroorbital bleeding at days 0, 2, 4,
5, 7, and 10 post-injection and capsid-associated viral DNA from
serum was quantitated by real time PCR analysis as described pre-
viously (Keasler et al., 2007). Compared to mice injected with pHBV,
there was a signiﬁcant reduction in capsid-associated viral DNA in
the serum of mice injected with pHBVΔX at days 2, 4, 5, and 7 post-
injection (pb0.05; Fig. 5, see asterisks). The maximum reduction in
viremia in the absence of HBx (mice injected with pHBVΔX; 97%Fig. 4. Subcellular localization of HBx-GFP fusion proteins in HepG2 cells. HepG2 cells w
deconvolution microscopy 24 h post-transfection. Localization of GFP tagged constructs is ill
the middle column (D–F), and a merged image can be seen in the right column (G–I).reduction) was recorded in sera collected at day 4 post-injection, a
result consistent with our previous ﬁndings (Keasler et al., 2007).
Viremia was restored to maximal pHBV levels in mice injected with
pHBVΔX plus pSI-X or pSI-NLS-X. However, pSI-NES-X was unable to
restore pHBVΔX replication, with levels of capsid-associated DNA
remaining nearly identical to that measured in mice injected with
pHBVΔX alone (Fig. 5). This result indicates that the requirement forere transfected with pSI-X-GFP, pSI-NLS-X-GFP, or pSI-NES-X-GFP and analyzed by
ustrated in the ﬁrst column (A–C), staining of the cell nucleus (by DAPI) can be seen in
126 V.V. Keasler et al. / Virology 390 (2009) 122–129nuclear-localized HBx in HBV replication identiﬁed in HepG2 cells
(Fig. 3A) is also apparent in mouse hepatocytes in vivo.
Discussion
The HBV regulatory X protein is required for virus replication
(Bouchard et al., 2002; Chen et al., 1993; Keasler et al., 2007; Zoulim
et al., 1994), but the mechanism through which it acts remains
unknown. In the present study, we tested the ability of HBx targeted
to or excluded from the nucleus to restore HBx-deﬁcient virus
replication. We show that in transfected HepG2 cells, the reduced
virus replication from the HBx-deﬁcient pHBVΔX plasmid was
restored to wildtype levels by nuclear-localized HBx but not by HBx
excluded from the nucleus. Deconvolution ﬂuorescence microscopy
experiments demonstrated that the NLS and NES signals targeted
HBx to the proper subcellular localization, and IP/Western blot was
used to verify the similar expression levels of NLS- and NES-HBx.
Importantly, dose-response experiments revealed that HBx can
restore pHBVΔX replication when HBx is expressed at levels below
detection by IP/Western. This study demonstrates that the localiza-
tion of HBx to the nucleus is essential for its role in virus replication
and that this requirement is evident in both human HepG2 cells and
in mouse hepatocytes in vivo.
There are at least two interpretations to the data showing that
NLS-HBx restores pHBVΔX replication. In the ﬁrst, HBx is predicted to
interact with a cellular target in the nucleus to provide some function
critical for HBV replication. This idea is supported by several studies,
including that HBx can stimulate transcription from reporter
constructs containing the HBV Enhancer I (Doria et al., 1995), leading
to a 2- to 3-fold increase in HBV mRNA levels in some (Keasler et al.,
2007; Leupin et al., 2005; Melegari et al., 2005; Tang et al., 2005;
Zhang et al., 2001) but not all (Bouchard et al., 2002) studies utilizing
the HBV replication assay. HBx also stimulates transcription when
tethered to a DNA-binding domain (Haviv et al., 1995; Seto et al.,
1990), and is reported to interact with the basic leucine zipper region
of CREB [cAMP response element-binding; (Barnabas et al., 1997;
Palmer et al., 1997; Williams and Andrisani, 1995)] and with binding
partner DDB1 (Lee et al., 1995; Leupin et al., 2005). Therefore, the
ﬁnding that nuclear-localized HBx restores HBx-deﬁcient replication
may be explained by any or all of the above previous studies.
A second major interpretation of our results, not mutually
exclusive from the above explanation of nuclear localization, is that
HBx may indeed interact with a critical cytoplasmic target, but
additionally require translocation to the nucleus to facilitate replica-
tion. Many studies report properties for HBx consistent with its
cytoplasmic localization, and so it is somewhat surprising that NES-
HBx provided no function in restoring pHBVΔX replication. In the
cytoplasm, HBx activates the Ras–Raf–MAP kinase cytoplasmic
signaling pathway (Benn et al., 1996; Benn and Schneider, 1994;
Cross et al., 1993; Natoli et al., 1994a; Natoli et al., 1994b), and the
stress-activated protein kinase/c-Jun NH2-terminal kinase (SAPK–
JNK) pathway (Benn et al., 1996; Henkler et al., 1998; Tarn et al.,
1999). These properties of HBx have been proposed to facilitate virus
replication, although the replication assay was not available for direct
testing at the time those studies were published. There are also
reports from several laboratories that a subpopulation of cytoplasmic
HBx localizes to the mitochondria (Henkler et al., 2001; Huh and
Siddiqui, 2002; McClain et al., 2007; Rahmani et al., 2000; Takada
et al., 1999; Waris et al., 2001). It is important to recall that these HBV
replication assays mimic some, but not all, steps in virus replication.
A recent study used the same replication assay to show that a modest
mitochondrial release of calcium may be linked to HBV replication
(McClain et al., 2007) However, that study did not speciﬁcally exa-
mine NLS-HBx or NES-HBx effects on calcium release, and so a direct
comparison with the present study is not possible. In summary, we
cannot eliminate the possibility that there are critical cytoplasmictargets of HBx that must translocate to the nucleus to participate in
virus replication.
The present study is the third to investigate the role of HBx
subcellular localization in virus replication, and our results both
support and differ from those previous studies (Table 1). One study
concluded that targeting of HBx to the nucleus had no effect on HBx-
deﬁcient replication, but did not examine HBx excluded from the
nucleus as a positive control (Klein et al., 2001). Our results do support
the ﬁndings of another study that utilized HBx-GFP fusion proteins
targeted either to the nucleus or the cytoplasm to restore HBx-
deﬁcient replication (Leupin et al., 2005). While the author's use of
the strong SRα promoter to drive HBx-GFP expression raised the
question of whether HBx expressed at more physiological levels
would behave similarly, we now report conﬁrmatory results when
HBx is expressed at very low levels, below the limits of detection.
The expression level of HBx is an important consideration in any
experiment designed to investigate HBx function. HBx expressed from
the strong CMV promoter is reported to form cytoplasmic granules in
cells expressing the highest levels of the protein (Henkler et al., 2001;
Hoare et al., 2001), and cell lines stably expressing HBx have reduced
growth rates relative to control cells (Lee et al., 1998). Indeed, the
relative promoter strengths of HBx expression constructs used in
different studies should be noted. For example, a previous study that
expressed HBx as GFP fusion proteins additionally utilized the SRα
promoter that is estimated to be 40-fold stronger than the SV40 early
promoter used in our study (Table 1). While a direct comparison of
HBx protein levels in the three studies is not possible, we demonstrate
here that HBx expressed at levels below detection in HepG2 cells is
still able to restore pHBVΔX replication. Furthermore, we calculate
that the amount of plasmid DNA taken up per cell via hydrodynamic
injection method was approximately 1% of that received per
transfected HepG2 cell (see Materials and methods), indicating even
lower levels of HBx in vivo are sufﬁcient to restore HBx-deﬁcient
replication. For these reasons, we conclude that HBx was not
overexpressed in our replication assays.
The ﬁnding that NLS-HBx restores HBVΔX replication in the
hydrodynamic injection model is an important ﬁrst step in character-
izing the function of HBx, in vivo in the context of virus replication and
in the presence of an intact immune system. It is thought that the
inability to infect mice with HBV is due to a lack of virus receptors on
mouse hepatocytes. It remains unknown whether this is the only
difference in virus replication between human and mouse hepato-
cytes, or whether these two models of HBV replicationwill eventually
diverge at some molecular level.
It is apparent from this study and others that while HBx-
deﬁciency is associated with a reproducible decrease in capsid-
associated DNA, virus replication is not completely eliminated
(Keasler et al., 2007; Leupin et al., 2005; Melegari et al., 2005; Tang
et al., 2005; Zhang et al., 2001). This residual HBx-independent
replication is consistently found when real time PCR is used to
quantitate virus copy number, and we have considered several
possible explanations. First, there may be occasional read-through of
the stop codon at HBx amino acid 7 resulting in very low levels of
HBx sufﬁcient to restore some replication. In addition, HBx is not
required for virus replication in actively dividing cells (Blum et al.,
1992), and it is possible that the HepG2 cell cultures used in our
replication studies are not completely contact-inhibited. Despite the
residual replication in the absence of HBx, the effect of HBx-
deﬁciency is reproducible and can be complemented by the addition
of a second plasmid encoding HBx.
After our experiments were completed, a new study was
published of a similar analysis in HepG2 cells (Cha et al., 2009).
Although the authors concluded that both NLS- and NES-HBx
contribute equally to HBV replication, a close examination of the
data revealed that NES-HBx activated pHBVΔX replication to signi-
ﬁcantly lower levels than did either HBx or NLS-HBx. A comparison
127V.V. Keasler et al. / Virology 390 (2009) 122–129with wildtype (pHBV) replication was not included. In addition, that
study expressed HBx under control of the strong CMV promoter,
shown by others to induce the formation of cytoplasmic granules
(Henkler et al., 2001; Hoare et al., 2001; Song et al., 2003). This may
provide an explanation for why Cha et al. found that HBx restores
pHBVΔX to 75% of wildtype (pHBV) replication (versus 100% restora-
tion in our study). Nevertheless, our ﬁndings are in general agree-
ment with the Cha study.
In summary, we have examined the requirement of HBx to restore
HBx-deﬁcient replication when HBx is targeted to, or excluded from,
the cell nucleus. While the HBV replication models used in our study
are not true infection models, they do provide the opportunity to
quantitate virus replication under varying conditions. These assays
represent the best experimental model available to test HBx function
in a biologically relevant setting. Our results clearly demonstrate that
nuclear localization of HBx is critical for maximal levels of capsid-
associated viral DNA in transfected HepG2 cells. These results do not
exclude the possibility that HBx may have critical cytoplasmic targets,
but do suggest that such interactions would require translocation to
the nucleus as part of the HBV replication strategy. Our results support
a previous report that NLS-HBx expressed as a GFP fusion protein can
restore HBx-deﬁcient replication in HepG2 cells (Leupin et al., 2005),
and extends those earlier studies by showing that this occurs when
HBx is expressed at more physiological levels. Importantly, we further
show that this property of HBx also occurs in an in vivo setting using
the hydrodynamic mouse model. Future experiments will seek to




Plasmid DNAs encoding a greater-than-unit length HBV genome
[payw1.2 (Scaglioni et al., 1997)] or the same plasmid containing a
stop codon at amino acid 7 [payw1.2⁎7 (Melegari et al., 1998)] were
obtained from the laboratory of Dr. Robert Schneider. For simplicity,
we refer to payw1.2 plasmid as pHBV and the HBx-deﬁcient plasmid
payw1.2⁎7 as pHBVΔX. Expression of HBV in these vectors is driven by
the native HBV promoter/enhancers (Brondyk, 1994). The parental
HBx expression plasmid used in this study, pSI-X, was created using a
plasmid containing the simian virus 40 enhancer/early promoter
vector (pSI; Promega) and the subtype adw2 HBx, as described pre-
viously (Keasler et al., 2007). pSI-NLS-HBXwas created by PCR cloning
using primers [5′GTAACGCGTATGCCAAAGAAGAAG CGAAAGGCTGC-
TAGGCTG′3 and 5′GTAGCGGCCGCTTAGGCAGAGG′3] that contain the
SV40 T antigen nuclear localization signal (Lanford and Butel, 1984).
pSI-NES-HBX was created using PCR primers [5′GTAACGCGTATGAAC-
GAGCTAGCACTAAAGCTAGCAGGTCTAGACATCAACAAGGCTGT-
CAGGCTG′3 and 5′GTAGCGGCCGCTTAGGCAGAGG′3] that contain the
nuclear export signal (NES) identiﬁed in the protein kinase inhibitor
alpha gene (Fukuda et al., 1997). GFP was added in frame to the
carboxy terminus of pSI-X, pSI-NLS-HBX, and pSI-NES-HBX by
linearizing a plasmid construct containing the entire GFP open
reading frame (pSI-GFP) using double restriction enzyme digest
with Mlu I and Sma I. The X sequence (including the NES or NLS
described above) was PCR ampliﬁed using the forward primers
described above (to add the NES and NLS respectively) and the
following primer to remove the stop codon from the X open reading
frame and to add a Not I restriction site: 5′ATGCCCGGGCAGAGGT-
GAAAAAG′3. The PCR ampliﬁed sequences for NLS-HBX and NES-HBX
were then ligated into the pSI-GFP vector. Removal of the stop codon
at the 3′ end of the NLS-HBX and NES-HBX constructs allows read-
through into the GFP nucleotide sequence creating an NLS-HBX-GFP
or NES-HBX-GFP fusion construct. A plasmid encoding a heat-stable,
secretable form of alkaline phosphatase (pSI-SEAP) was constructedas previously described (Keasler et al., 2007). A promoterless pSEAP2-
basic plasmid (Clontech) was used as a negative control. All plasmid
DNAs were transformed into Escherichia coli and plasmid preparations
made using an Endofree Plasmid Maxi kit (Qiagen).
Cell culture and plasmid transfection
Human liver HepG2 cells were obtained directly from the ATCC and
used at early passages. Cells were plated and maintained in Eagles
minimal media plus 10% fetal bovine serum. The replication assay in
HepG2 cells was performed as previously described (Keasler et al.,
2007). Brieﬂy, 5×105 cells were plated in 60 mm dishes and
transfected 24 h later using TransIT (Mirus Bio Corporation) according
to the manufacturer's protocol. For HBV replication experiments,
2×106 untransfected HepG2 cells were added to each 60-mm dish at
2 h post-transfection to create the conﬂuent monolayer needed for
this assay and cells were harvested at 5 days post-transfection.
Hydrodynamic injection and retroorbital collection of blood
Approval for all experiments involving animals was obtained
from the Institutional Animal Care and Use Committee at Baylor
College of Medicine. Hydrodynamic injections were performed on
outbred Crl:CD-1 (ICR) female mice at 10–13 weeks of age as pre-
viously described (Keasler et al., 2007). Brieﬂy, mice were injected
with plasmid DNA diluted in phosphate-buffered saline (PBS) to a
volume equivalent to 8% of the total body weight of each animal.
Each injected mouse received a total of 18 μg plasmid DNA: 9 μg of
HBV plasmid DNA (either pHBV or pHBVΔX), 5 μg pSI-SEAP
(encoding secretable, heat-stable alkaline phosphatase), and 4 μg
of pSI-X, pSI-NLS-X, pSI-NES-X, or control plasmid. Negative control
animals received 5 μg pSI-SEAP and 13 μg of promoterless pSEAP2-
Basic plasmid DNA. Approximately 50 μl of blood was collected from
each mouse on days 0, 2, 4, 5, 7, and 10 post-injection by retroorbital
bleeding to measure viremia as previously described (Keasler et al.,
2007).
Measurement of heat-stable alkaline phosphatase
Animal to animal injection variability was controlled by normal-
izing to levels of heat-stable alkaline phosphatase (expressed from
the pSI-SEAP plasmid DNA) detected in the serum at day 4 post-
injection (Keasler et al., 2007). Brieﬂy, serum collected by retro-
orbital bleeding was heated at 65 °C for 30 min to inactivate
endogenous phosphatases, diluted in sterile saline, and mixed with
alkaline phosphatase yellow (pNPP) liquid substrate (Sigma). The
optical density at 405 nm was then recorded at 0, 10, 20, and 30 min
to determine relative alkaline phosphatase levels among groups of
injected mice.
Estimation of plasmid DNA per cell
HepG2 cells (5×105 per 60-mm plate) were transfected with
2 μg HBV plasmid DNA. Using an estimated transfection efﬁciency of
20% (determined by cotransfection with a plasmid DNA encoding
GFP), a total of 1×105 HepG2 cells received plasmid for an average
of 20 pg of HBV plasmid DNA per cell (assuming all plasmid DNA
was taken up). In comparison, a normal mouse liver contains
approximately 108 hepatocytes (Sohlenius-Sternbeck, 2006), and
hydrodynamic injection of plasmid DNA encoding beta-galactosidase
led to the conclusion that 40% (4×107) hepatocytes expressed beta-
galactosidase (Liu et al., 1999). In our study, each mouse received
9 μg HBV plasmid DNA, for a total of 0.225 pg of DNA per transfected
hepatocyte. The actual amount per cell is likely less, since plasmid
DNA delivered by hydrodynamic injection can also be taken up in
other organs (Liu et al., 1999).
128 V.V. Keasler et al. / Virology 390 (2009) 122–129Detection of HBx by immunoprecipitation (IP) and Western Blot
Transfected HepG2 cells were harvested and pooled (two 60-mm
plates per IP) at 48 h post-transfection as previously described
(Becker et al., 1998). Proteins were separated by 15% SDS-PAGE and
transferred to a nitrocellulose membrane. HBx was detected using a
rabbit polyclonal antibody (1:1000), an anti-rabbit secondary anti-
body conjugated to horseradish peroxidase (1:1000; Pierce), and the
SuperSignal West Femto detection kit (Pierce).
Deconvolution ﬂuorescence microscopy of HepG2 cells
HepG2 cells were plated on poly-D-lysine coated coverslips in
24-well plates at 5×104 cells per well. Cells were transfected 24 h
later using TransIT (Mirus Bio Corporation) according to the
manufacturer's protocol. Transfected cells were ﬁxed and visualized
24 h after transfection. Brieﬂy, coverslips were washed with ice-cold
PBS (containing Ca++ and Mg++) and ﬁxed with 4% formaldehyde
in PEM buffer [80 mM Potassium PIPES (pH 6.8), 5 mM EGTA, (pH
7.0) and 2 mM MgCl2] on ice. Coverslips were washed with PEM
buffer, and auto-ﬂuorescence quenched by addition of 0.1 M
ammonium chloride. Cells were then permeabilized by the addition
of 0.5% Triton X-100 in PEM buffer, washed with PEM buffer, and
the nuclei stained with DAPI. Finally, coverslips were mounted on
slides with Anti-fade mounting media. Transfected cells were
visualized using a DeltaVision (Deconvolution) Restoration Micro-
scope equipped with a Plan-APOCHROMAT 63×/1.40 objective and
pictures acquired using SoftWoRx software.
Puriﬁcation of capsid-associated viral DNA
Capsid-associated viral DNA was extracted and quantitated from
transfected HepG2 cells and from serum of hydrodynamically-
injected mice, as previously described (Keasler et al., 2007). Brieﬂy,
HepG2 cells were lysed (50 mM Tris, pH 7.5, 0.5% NP-40, 1 mM EDTA,
and 100 mM NaCl) and then incubated with 10 μl of 1 M MgCl2 and
10 μl of DNaseI (10 mg/ml). Viral cores were next precipitated from
solution by the addition of EDTA and polyethylene glycol and the
pellet resuspended in 500 μl buffer containing 10 mM Tris, 100 mM
NaCl, 1 mM EDTA, 1% sodium dodecyl sulfate (SDS), and 20l of
25 mg/ml proteinase K. Viral DNAs released from lysed cores were
extracted with phenol and chloroform, precipitated with isopropanol,
and resuspended in Tris-EDTA. Puriﬁcation of capsid-associated viral
DNA from serum was nearly identical to that described for
transfected HepG2 cells. However, serum was treated with DNaseI
overnight and viral DNAs from lysed cores were concentrated using a
QIAamp DNA Blood Mini kit (QIAGEN) following the manufacturer's
protocol (instead of phenol and chloroform extraction and isopro-
panol precipitation).
Real-time PCR detection of HBV DNA
Quantitation of capsid-associated viral DNAwas performed by real
time PCR using a primer/probe set (Applied Biosystems), as
previously described (Keasler et al., 2007). All samples were analyzed
in duplicate using a 96-well plate format and the Applied Biosystems
7000 Sequence Detection System with the following cycling para-
meters: 1 cycle at 50 °C for 2 min; 1 cycle at 95 °C for 10 min; and 40
cycles at 95 °C for 15 s and 60 °C for 60 s. Standard curves were
included in all real time PCR reactions using the pHBV plasmid DNA
diluted over a large dynamic range (107 to 100).
Quantitation and statistics
Statistical signiﬁcance for all experiments was determined by
using the Student's t test (Microsoft Excel software package). Errorbars are reported as standard errors of the means, and signiﬁcance
was assigned for p values of b0.05.
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